Skip to main content

Advertisement

SpringerLink
Log in

Ranibizumab versus dexamethasone implant for central retinal vein occlusion: the Ranidex study

  • Letter to the Editor
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Chatziralli I, Theodossiadis G, Kabanarou SA, Parikakis E, Xirou T, Mitropoulos P, Theodossiadis P (2017) Ranibizumab versus dexamethasone implant for central retinal vein occlusion: the Ranidex study. Graefes Arch Clin Exp Ophthalmol. doi:10.1007/s00417-017-3719-5 Published online June 15, 2017

  2. Freund KB, Korobelnik JF, Deveny R et al (2015) Treat-and extend regimens with anti-VEGF agents in retinal diseases. Retina 35:1489–1506

    Article  CAS  PubMed  Google Scholar 

  3. Gover S, Murthy RK, Brar VS, Chalam KV (2009) Normative data for macular thickness by high-definition spectral-domain optical coherence tomography (Spectralis). Am J Ophthalmol 148:266–271

    Article  Google Scholar 

  4. Kuppermann BD, Haller JA, Bandello F (2014) Onset and duration of visual acuity improvement after dexamethasone intravitreal implant in eyes with macular edema due to vcretinal vein occlusion. Retina 34:1743–1749

    Article  CAS  PubMed  Google Scholar 

  5. Campochiaro PA, Brown DM, Awh CC, Lee SY, Gray S, Saroj N, Murahashi WY, Rubio RG (2011) Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase lll study. Ophthalmology 118:2041–2049

    Article  PubMed  Google Scholar 

  6. Haller JA, Bandello F, RJr B, Blumenkranz MS, Gilles M, Heier J, Loewenstein A, Yoon YH, Jiao J, Li XY, Whitcup SM (2011) Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion: twelve-month study results. Ophthalmology 118(Ozurdex Geneva Study Group):2453–2560

    Article  PubMed  Google Scholar 

  7. Călugăru D, Călugăru M (2015) Intravitreal bevacizumab in acute central/hemicentral retinal vein occlusions: three-year results of a prospective clinical study. J Ocul Pharmacol Ther 31:78–86

    Article  PubMed  Google Scholar 

  8. Călugăru D, Călugăru M (2017) Treatment patterns of ranibizumab intravitreal injection and dexamethasone intravitreal implant for retinal vein occlusion in the USA. Eye 31:1112–1113

  9. Călugăru D, Călugăru M (2017) Baseline choroidal thickness as a predictor for treatment oucomes in central retinal vein occlusion. Am J Ophthalmol 176:257–258

    PubMed  Google Scholar 

  10. Călugăru D, Călugăru M (2017) Dexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trial. Graefes Arch Clin Exp Ophthalmol 255:427–428

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

All authors have completed and submitted the ICMJE form for disclosure of potential conflicts of interest. No financial disclosures. Both authors (D.C. and M.C.) were involved in the design and conduct of the study; collection, management, analysis and interpretation of the data; and preparation, review or approval of the manuscript.

The authors have full control over the primary data and they agree to allow Graefe’s Archive for Clinical and Experimental Ophthalmology to review their data if requested.

Author information

Authors and Affiliations

  1. Department of Ophthalmology, University of Medicine Cluj-Napoca/Romania, Cluj-Napoca, Romania

    Dan Călugăru & Mihai Călugăru

Authors
  1. Dan Călugăru
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mihai Călugăru
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mihai Călugăru.

Ethics declarations

Conflict of interest

All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Călugăru, D., Călugăru, M. Ranibizumab versus dexamethasone implant for central retinal vein occlusion: the Ranidex study. Graefes Arch Clin Exp Ophthalmol 255, 2073–2075 (2017). https://doi.org/10.1007/s00417-017-3749-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-017-3749-z

Search

Navigation